Dynamics of microcystins-LR and -RR in the phytoplanktivorous silver carp in a sub-chronic toxicity experiment

被引:171
作者
Xie, LQ
Xie, P [1 ]
Ozawa, K
Honma, T
Yokoyama, A
Park, HD
机构
[1] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan 430072, Peoples R China
[2] Shinshu Univ, Fac Sci, Dept Environm Sci, Matsumoto, Nagano 3908621, Japan
基金
中国国家自然科学基金;
关键词
sub-chronic toxicity experiment; microcystin-LR and -RR; Microcystis viridis; phytoplanktivorous sliver carp; deputation; evolution;
D O I
10.1016/j.envpol.2003.08.011
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A sub-chronic toxicity experiment was conducted to examine tissue distribution and depuration of two microcystins (microcystin-LR and microcystin -RR) in the phytoplanktivorous filter-feeding silver carp during a course of 80 days. Two large tanks (A, B) were used, and in Tank A, the fish were fed naturally with fresh Microcystis viridis cells (collected from a eutrophic pond) throughout the experiment, while in Tank B, the food of the fish were M. viridis cells for the first 40 days and then changed to artificial carp feed. High Performance Liquid Chromatography (HPLC) was used to measure MC-LR and MC-RR in the M. viridis cells, the seston, and the intestine, blood, liver and muscle tissue of silver carp at an interval of 20 days. MC-RR and MC-LR in the collected Microcystis cells varied between 268-580 and 110-292 mug g(-1) DW, respectively. In Tank A, MC-RR and MC-LR varied between 41.5-99.5 and 6.9-15.8 mug g(-1) DW in the seston, respectively. The maximum MC-RR in the blood, liver and muscle of the fish was 49.7, 17.8 and 1.77 mug g(-1) DW, respectively. No MC-LR was detectable in the muscle and blood samples of the silver carp in spite of the abundant presence of this toxin in the intestines (for the liver, there was only one case when a relatively minor quantity was detected). These findings contrast with previous experimental results on rainbow trout. Perhaps silver carp has a mechanism to degrade MC-LR actively and to inhibit MC-LR transportation across the intestines. The depuration of MC-RR concentrations occurred slowly than uptakes in blood, liver and muscle, and the depuration rate was in the order of blood > liver > muscle. The grazing ability of silver carp on toxic cyanobacteria suggests an applicability of using phytoplanktivorous fish to counteract cyanotoxin contamination in eutrophic waters. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 42 条
[1]  
Bury NR, 1996, J EXP BIOL, V199, P1319
[2]   Liver damage in brown trout, Salmo trutta L, and rainbow trout, Oncorhynchus mykiss (Walbaum), following administration of the cyanobacterial hepatotoxin microcystin-LR via the dorsal aorta [J].
Bury, NR ;
McGeer, JC ;
Eddy, FB ;
Codd, GA .
JOURNAL OF FISH DISEASES, 1997, 20 (03) :209-215
[3]   In vivo and in vitro intestinal transport of 3H-microcystin-LR, a cyanobacterial toxin, in rainbow trout (Oncorhynchus mykiss) [J].
Bury, NR ;
Newlands, AD ;
Eddy, FB ;
Codd, GA .
AQUATIC TOXICOLOGY, 1998, 42 (02) :139-148
[4]   Health effects of toxin-producing cyanobacteria: "The CyanoHABs" [J].
Carmichael, WW .
HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2001, 7 (05) :1393-1407
[5]  
CHEN JC, 1995, FISHERY SCI INFORM, V22, P169
[6]  
Chen SL, 1990, ECOLOGICAL STUDIES L, P292
[7]   Cyanobacterial toxins: Occurrence, properties and biological significance [J].
Codd, GA .
WATER SCIENCE AND TECHNOLOGY, 1995, 32 (04) :149-156
[8]   A MODEL SYSTEM FOR STUDYING THE BIOAVAILABILITY OF INTESTINALLY ADMINISTERED MICROCYSTIN-LR, A HEPATOTOXIC PEPTIDE FROM THE CYANOBACTERIUM MICROCYSTIS-AERUGINOSA [J].
DAHLEM, AM ;
HASSAN, AS ;
SWANSON, SP ;
CARMICHAEL, WW ;
BEASLEY, VR .
PHARMACOLOGY & TOXICOLOGY, 1989, 64 (02) :177-181
[9]   The toxicology of microcystins [J].
Dawson, RM .
TOXICON, 1998, 36 (07) :953-962
[10]   Pathological and biochemical characterization of microcystin-induced hepatopancreas and kidney damage in carp (Cyprinus carpio) [J].
Fischer, WJ ;
Dietrich, DR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 164 (01) :73-81